C12N 2770/14034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2770/14034 (Use of virus or viral component as vaccine) appears on 6 US grants and 14 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 14
- Assignees
- 6
- Inventors
- 18
- Latest grant
- 18 Feb 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 2 |
| 2021 | 2 | 1 |
| 2022 | 1 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 7 |
By publication year.
Recent patents
- Treatment of insect bite hypersensitivity18 Feb 2025US 12,226,475 B2UniversitäT ZüRich
- Covalently fused viral coat proteins for the display of target molecules4 Apr 2023US 11,618,771 B2Fraunhofer USA, Inc.
- Treatment of insect bite hypersensitivity12 Jul 2022US 11,382,970 B2UniversitäT ZüRich
- Covalently fused viral coat proteins for the display of target molecules3 Aug 2021US 11,078,240 B2Fraunhofer USA, Inc.
- Treatment of peanut allergy26 Jan 2021US 10,898,569 B2Allergy Therapeutics (UK) Limited
- Treatment of insect bite hypersensitivity4 Dec 2025US 2025/0367273 A1UniversitäT ZüRich
- Active vaccination for the treatment of ngf-related disorders11 Sep 2025US 2025/0281584 A1Boehringer Ingelheim Vetmedica GmbH
- Veterinary compositions of modified virus-like particles of cmv and il-1 beta mutein antigens11 Sep 2025US 2025/0281585 A1
- Veterinary compositions of modified virus-like particles of cmv and canine il-1 beta mutein antigens11 Sep 2025US 2025/0281586 A1
- Veterinary compositions of modified virus-like particles of cmv and feline il-1 beta mutein antigens11 Sep 2025US 2025/0281587 A1
Most cited
By later US patents